St. George's University of London selects GenoLogics platform and data management system for biomarker discovery
GenoLogics Life Sciences Software Inc. (GenoLogics) announced that the St. George's, University of London (SGUL) Medical Biomics Centre has selected GenoLogics to provide their lab and scientific data management system. The SGUL Medical Biomics Centre is a centre for the integration of genomics, transcriptomics, proteomics and metabolomics technologies applied to medical and biomedical research. It is well provisioned with cutting edge instrumentation and has a significant track record across systems biology areas with proven success in biomarker discovery, identification and validation.
Most read news
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Antitope and Synthon announce collaboration
Analysis by AlgoNomics reveals that Anticalins have an immunogenicity level comparable to the wild-type human lipocalin
Cellectis Acquires Vectocell Technology to Accelerate Therapeutic Development Programs
New data for Menveo vaccine show excellent immune response and broad protection for infants against meningococcal meningitis - Menveo (MenACWY-CRM) the first quadrivalent conjugated meningitis vaccine to demonstrate an excellent immune response in infants
Kentucky Bioprocessing, Icon Genetics and Mapp Biopharmaceutical have entered into discussions to merge their businesses
